Table outlining diagnoses of index and control groups, age, gender, number of participants, and main outcome measures for some of the studies of non-malignant conditions discussed
Study | Index group diagnoses | Control group diagnoses | Number of subjects | Subjects: gender age (years) | No. of controls | Controls: gender age (years) | Main outcome measures used | |||||||
9Pless et al, 1989 | Heterogeneous | Birth cohort—no chronic illness | 467 at start | Boys > girls | 4895 at start | Last assessed 36 | 1-150PSE10 aged 36, sociodemographic enquiry | |||||||
Last assessed 36 | ||||||||||||||
8Jacobson et al, 1997 | IDDM | Acute medical problem same year as subject recruited | 57 | 29M, 28F | 54 | 36M, 18F | Sociodemographic enquiry, Symptom Checklist (SCL-90),11 Harter Perceived Competence Scale12 | |||||||
Mean 22.9, SD 2.1 | Mean 22.9, SD 2 | |||||||||||||
13Kokkonen and Kokkonen, 1993 | Heterogeneous | General pop. controls | 407 | 223M, 184F | 202 | 99M, 103F | 1-150PSE10 | |||||||
18–25 | ||||||||||||||
14Kokkonen, 1995 | Heterogeneous | General pop. controls | 487 | 265M, 222F | 202 | 99M, 103F | Sociodemographic enquiry | |||||||
22.1 (19–25) | ||||||||||||||
15 Morton et al, 1994 | Renal disorders (paediatric dialysis and transplant prog.) | Healthy controls (GP registers) | 45 | 21M, 24F | 48 | 25M, 23F | 1-150SADS-L,16 Rosenberg Self-esteem Scale17 | |||||||
Mean 24.8, SD 3.7 | Mean 24.7, range 17–35 | |||||||||||||
18 Reynolds et al, 1993 | Renal disorders (as above) | Healthy controls | 45 | 21M, 24F | 48 | 25M, 23F | Sociodemographic enquiry, Stress and Social Support Inventory19 | |||||||
Mean 24.8, range 17–35 | Mean 25 (4.1) | |||||||||||||
20Pearson et al, 1991 | Cystic fibrosis adults | Cystic fibrosis children | 36 | 20M, 16F | 61 | 34M, 27F | EAT,21 STAIC,22CDI,23 STAI,24 ZUNG,25 SCL-9011 | |||||||
24.8 (16–40) | 10.96 (8–15) | |||||||||||||
26Blair et al, 1993 | Cystic fibrosis | Anorexia | 29 | 20M, 9F | (a) 27 | (a) 2M, 25F | Structured clinical interview for psychiatric disorder, GHQ27 | |||||||
Healthy controls | 19.2 (2.7) | (b) 31 | 18.7 (3.2) | |||||||||||
(b) 8M, 23F | ||||||||||||||
18.2 (2.6) | ||||||||||||||
28Walters et al, 1993 | Cystic fibrosis | N/A | 866 | 423M, 397F | N/A | N/A | Sociodemographic enquiry | |||||||
Median 22, 17–67 | ||||||||||||||
29David et al, 1994 | Juvenile arthritis (JCA) | N/A | 43 | M:F, 1:3 | N/A | N/A | BDI,30 GHQ27 | |||||||
Mean 26.7, SD 7.8 | ||||||||||||||
31Petersonet al, 1997 | Juvenile arthritis | Clinic attenders without JCA | 44 | 13M, 31F | 102 | 29M, 73F | Sociodemographic enquiry | |||||||
Median 33.5, 19–45 | 33.6 (19–49) | |||||||||||||
32Utenset al, 1994 | Congenital heart disease (surgically corrected) | General population | 288 | 147 M, 141F | 336 | 223M, 113F | Dutch Personality Questionnaire,33 sociodemographic enquiry | |||||||
Mean age 22.7 | Mean 22.2 |
Sociodemographic information was obtained by self report questionnaire or by interview in different studies.
↵1-150 Validated psychiatric research interview. All other named psychiatric status measures are self report questionnaires.
IDDM, insulin dependent diabetes mellitus; PSE, Present State Examination; SADS-L, Schedule for Affective Disorders and Schizophrenia, Life-time version; GHQ, General Health Questionnaire; EAT, Eating Attitudes Test; STAI(C), Stait–Trait Anxiety Inventory (for Children); CDI, Child Depression Inventory; ZUNG, Zung Self-Report Depression Inventory; BDI, Beck Depression Inventory.